You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.

Skip to main content Skip to search

Guidelines & Advice

About Guidelines Email Guidelines Team

What's New in Guidelines & Advice

All documents recently added to the Guidelines & Advice area within the last 6 months are available here, as well as any updated documents.

Role of Adjuvant Treatment in Resected Pancreatic Ductal Adenocarcinoma

Document Status: Current

ID: GL 2-33

Version: 2

New

Jun 2025

Follow-up for Cervical Cancer

Document Status: Current

ID: 4-16

Version: 2

May 2025

Effective Teaching Strategies and Methods for Cancer Patient Education

Document Status: Current

ID: GL 20-2

Version: 2

Apr 2025

An Endorsement of the 2023 International Stereotactic Radiosurgery Society’s (ISRS) Guideline: A Systematic Review Informing the Management of Symptomatic Brain Radiation Necrosis After Stereotactic Radiosurgery and ISRS Recommendations

Document Status: Current

ID: Guideline Endorsement C50-CIDAP-3

Mar 2025

Postmastectomy Breast Reconstruction in Patients with Non-Metastatic Breast Cancer

Document Status: Current

ID: GL 17-10 v2

Version: 2

Mar 2025

Evidence from Primary Studies and Systematic Reviews and Recommendations from Clinical Practice Guidelines January to June 2024

Document Status: Current

ID: PET 2024-1

Mar 2025

Ontario Cervical Screening Program recommendations for cervical screening and colposcopy with human papillomavirus testing in Ontario

Mar 2025

Ontario Cervical Screening Program: Guidance for Vaginal Vault Testing

Document Status: Current

Mar 2025

T-Cell Engaging Antibodies: Management of Cytokine Release Syndrome (CRS) and Immune Effector-Associated Neurotoxicity Syndrome (ICANS)

Document Status: Current

Mar 2025

Ontario Cervical Screening Program: Interim guidance to support the transition years following the launch of human papillomavirus testing in Ontario: Cervical screening and colposcopy recommendations for people ages 21 to 24

Document Status: Current

Mar 2025

The Use of Molecular Tools for Identifying and Guiding Treatment of Cancers of Unknown Primary

Document Status: Current

ID: MOTAC-7

Jan 2025